LL-37 Research for Antimicrobial Resistance
An evidence-based overview of research examining LL-37 in the context of antimicrobial resistance. This page synthesizes findings from peer-reviewed literature.
Research Summary
LL-37 and other antimicrobial peptides are being investigated as alternatives to traditional antibiotics in the face of antibiotic resistance. The membrane-disrupting mechanism is difficult for bacteria to develop resistance against. The peptide shows activity against multidrug-resistant organisms including MRSA and VRE. Synergistic effects with conventional antibiotics have been demonstrated. Development challenges include peptide stability, cost of production, and delivery. Synthetic analogs and mimetics are being developed to overcome these limitations.
Referenced Studies
Click any PMID to view the full study on PubMed.
Other Peptides Studied for Antimicrobial Resistance
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. LL-37 may have regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.